EW News and Press, Edwards Lifesciences Corporation From 08/05/23

2023-08-05 16:00:22 ET The US could see the largest number of approvals for medtech devices in around 10 years given the high number of approvals the US FDA granted in the first half of 2023. The agency's Center for Devices and Radiological Health in H1 approved or cleared 45 new device...

2023-07-31 10:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-07-27 08:38:02 ET Mersana Therapeutics ( MRSN ) -74% announces topline data from UPLIFT clinical trial in patients with platinum-resistant Ovarian Cancer and strategic reprioritization. Biohaven ( BHVN ) -27% . Yellow Corporation ( YELL ) -26% . ...

2023-07-26 20:43:05 ET Edwards Lifesciences Corporation (EW) Q2 2023 Earnings Conference Call July 26, 2023, 05:00 PM ET Company Participants Mark Wilterding - SVP, IR and Treasurer Bernard Zovighian - CEO Scott Ullem - CFO Larry Wood - Group President, TAVR ...

2023-07-26 16:17:15 ET Edwards Lifesciences press release ( NYSE: EW ): Q2 Non-GAAP EPS of $0.66 beats by $0.01 . Revenue of $1.53B (+11.7% Y/Y) beats by $20M . All product groups achieved double digit constant currency sales growth in Q2 Q2 TAVR sales grew...

2023-07-23 12:00:31 ET Soon after Johnson & Johnson ( NYSE: JNJ ) topped expectations with its Q2 2023 results last week, Baird came up with a report indicating brighter days for MedTech, mainly due to accelerating medical procedure volumes and a waning COVID impact in China. ...

2023-07-21 20:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON JULY 26, 2023 PR Newswire IRVINE, Calif. , July 19, 2023 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended June 30, 2023 after the market clos...

2023-07-09 12:00:00 ET Despite a disappointing start to 2023, the healthcare sector has several promising industries waiting to outperform this year, Goldman Sachs said in a recent report after the bank concluded its annual healthcare conference in Dana Point, California, last month. Th...

2023-06-12 23:39:04 ET Summary Edwards Lifesciences is still reporting solid top-line growth in Q1/23 but the bottom line declined and fiscal 2022 also saw low growth rates. Aside from actual growth rates in the last few quarters, Edwards Lifesciences is a high-quality business wi...